|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003015,
umls-concept:C0003234,
umls-concept:C0018787,
umls-concept:C0277785,
umls-concept:C0278704,
umls-concept:C0443252,
umls-concept:C1442488,
umls-concept:C1516231,
umls-concept:C1521970,
umls-concept:C1707689,
umls-concept:C2603343
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-10-1
|
|
pubmed:abstractText |
The ACE Inhibitor After Anthracycline (AAA) study is a randomized, double-blind, controlled clinical trial comparing enalapril with placebo to determine whether treatment can slow the progression of cardiac decline in patients who screen positive for anthracycline cardiotoxicity.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
pubmed-author:BarberGG,
pubmed-author:ClarkB JBJ,
pubmed-author:CnaanAA,
pubmed-author:CohenM IMI,
pubmed-author:DelaatCC,
pubmed-author:GaryP PPP,
pubmed-author:HogartyA NAN,
pubmed-author:KimballT RTR,
pubmed-author:ParidonS MSM,
pubmed-author:RutkowskaUU,
pubmed-author:RychikJJ,
pubmed-author:SilberJ HJH,
pubmed-author:SteinherzL JLJ,
pubmed-author:TartaglioneM RMR,
pubmed-author:ZhaoHH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
142
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
577-85
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11579345-Adolescent,
pubmed-meshheading:11579345-Adult,
pubmed-meshheading:11579345-Age Factors,
pubmed-meshheading:11579345-Algorithms,
pubmed-meshheading:11579345-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:11579345-Anthracyclines,
pubmed-meshheading:11579345-Child,
pubmed-meshheading:11579345-Child, Preschool,
pubmed-meshheading:11579345-Disease Progression,
pubmed-meshheading:11579345-Double-Blind Method,
pubmed-meshheading:11579345-Enalapril,
pubmed-meshheading:11579345-Female,
pubmed-meshheading:11579345-Heart Diseases,
pubmed-meshheading:11579345-Heart Function Tests,
pubmed-meshheading:11579345-Humans,
pubmed-meshheading:11579345-Infant,
pubmed-meshheading:11579345-Male,
pubmed-meshheading:11579345-Neoplasms,
pubmed-meshheading:11579345-Placebos,
pubmed-meshheading:11579345-Research Design,
pubmed-meshheading:11579345-Statistics, Nonparametric
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors.
|
|
pubmed:affiliation |
Division of Pediatric Oncology, Department of Pediatrics, Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. Silber@email.chop.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
